A Phase 3 Study of elacestrant versus standard endocrine therapy in node-positive ER+, HER2- early breast cancer with high risk of recurrence (ELEGANT)
A Phase 3 Study of elacestrant versus standard endocrine therapy in node-positive ER+, HER2- early breast cancer with high risk of recurrence (ELEGANT)
Trial Category:
Breast
Phase
III
Contact(s)
Kailash Mosalpuria, MD, MPH, FACP
Phone
402-484-4900
Fax
402-991-8850
Dr. Kailash Mosalpuria
402-484-4900
Bryan Medical Center
4004 Pioneer Woods Drive
Lincoln, NE 68506
https://clinicaltrials.gov/study/NCT06492616?cond=elacestrant&page=2&rank=16#contacts-and-locations
